The All India Institute of Medical Sciences in Delhi will on Tuesday begin screening children in the age group of 6-12 years for the clinical trials of Bharat Biotech’s Covaxin.
Dr Sanjay Rai, professor at the Centre for Community Medicine at Aiims said the selection for clinical trials in the 12-18 years is already over and children within this age group have been administered with a single dose of the vaccine.
Once the recruitment of children from 6-12 years is done, Aiims New Delhi will begin trials for children between 2 and 6 years.
Prior to Delhi, Aiims Patna started paediatric trials for Covaxin on 12-18 years from June 3.